Jason Scott Slakter Insider Trading for May 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jason Scott Slakter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Jason Scott Slakter for May 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.10 | 2,000 | 6,200 | 916,254 | 914.3 K to 916.3 K (+0.22 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 682 | 2,135 | 914,254 | 913.6 K to 914.3 K (+0.07 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 100 | 314 | 913,572 | 913.5 K to 913.6 K (+0.01 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 300 | 942 | 913,472 | 913.2 K to 913.5 K (+0.03 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.11 | 100 | 311 | 913,172 | 913.1 K to 913.2 K (+0.01 %) |
| May 26 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.09 | 500 | 1,545 | 913,072 | 912.6 K to 913.1 K (+0.05 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.10 | 300 | 930 | 912,572 | 912.3 K to 912.6 K (+0.03 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.06 | 800 | 2,448 | 912,272 | 911.5 K to 912.3 K (+0.09 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.07 | 8 | 25 | 911,472 | 911.5 K to 911.5 K (0.00 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.09 | 100 | 309 | 911,464 | 911.4 K to 911.5 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.07 | 2,595 | 7,967 | 911,364 | 908.8 K to 911.4 K (+0.29 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.09 | 700 | 2,163 | 908,769 | 908.1 K to 908.8 K (+0.08 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.08 | 1,600 | 4,928 | 908,069 | 906.5 K to 908.1 K (+0.18 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.12 | 200 | 624 | 906,469 | 906.3 K to 906.5 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.15 | 200 | 630 | 906,269 | 906.1 K to 906.3 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.16 | 100 | 316 | 906,069 | 906 K to 906.1 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.17 | 500 | 1,585 | 905,969 | 905.5 K to 906 K (+0.06 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 200 | 628 | 905,469 | 905.3 K to 905.5 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 200 | 626 | 905,269 | 905.1 K to 905.3 K (+0.02 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.11 | 267 | 830 | 905,069 | 904.8 K to 905.1 K (+0.03 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.12 | 1,337 | 4,171 | 904,802 | 903.5 K to 904.8 K (+0.15 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 89 | 278 | 903,465 | 903.4 K to 903.5 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.13 | 803 | 2,513 | 903,376 | 902.6 K to 903.4 K (+0.09 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.14 | 357 | 1,121 | 902,573 | 902.2 K to 902.6 K (+0.04 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.15 | 1,516 | 4,775 | 902,216 | 900.7 K to 902.2 K (+0.17 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.16 | 3,121 | 9,862 | 900,700 | 897.6 K to 900.7 K (+0.35 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.17 | 6,851 | 21,718 | 897,579 | 890.7 K to 897.6 K (+0.77 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.18 | 1,588 | 5,050 | 890,728 | 889.1 K to 890.7 K (+0.18 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.19 | 1,248 | 3,981 | 889,140 | 887.9 K to 889.1 K (+0.14 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.20 | 446 | 1,427 | 887,892 | 887.4 K to 887.9 K (+0.05 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.21 | 1,516 | 4,866 | 887,446 | 885.9 K to 887.4 K (+0.17 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.22 | 89 | 287 | 885,930 | 885.8 K to 885.9 K (+0.01 %) |
| May 25 2016 | OHRP | Ohr Pharmaceutical ... | Slakter Jason Scott | Chief Executive Off ... | Buy | P | 3.23 | 1,337 | 4,319 | 885,841 | 884.5 K to 885.8 K (+0.15 %) |